Search research articles
Contact Us
Filters
Showing results (81-90 of 109) with videos related to
Page
of 11
Sort By:
Scientific Reports
|
March 5, 2022
The sGC stimulator BAY-747 and activator runcaciguat can enhance memory in vivo via differential hippocampal plasticity mechanisms
Ellis Nelissen, Nina Possemis, Nick P Van Goethem, et al.
Nitric Oxide : Biology and Chemistry
|
December 6, 2021
Capillary hemodynamics and contracting skeletal muscle oxygen pressures in male rats with heart failure: Impact of soluble guanylyl cyclase activator
Ramona E Weber, Kiana M Schulze, Trenton D Colburn, et al.
The Journal of Sexual Medicine
|
April 24, 2010
Sex steroid receptors in male human bladder: expression and biological function
Aravinda K Chavalmane, Paolo Comeglio, Annamaria Morelli, et al.
Experimental Physiology
|
June 20, 2025
Effects of soluble guanylyl cyclase stimulation on muscle oxygenation and exercise capacity in heart failure with mildly reduced ejection fraction
Ramona E Weber, Kiana M Schulze, Andrew G Horn, et al.
British Journal of Pharmacology
|
June 25, 2026
Pharmacological activation of NO-cGMP signalling attenuates metabolic dysfunction-associated steatohepatitis
Krithika Rajeeth, Malte Roessing, Moritz Lehners, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
September 22, 2021
Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney disease
Agnès Bénardeau, Antje Kahnert, Tibor Schomber, et al.
Molecular Pharmacology
|
September 7, 2017
NO-Sensitive Guanylate Cyclase Isoforms NO-GC1 and NO-GC2 Contribute to Noise-Induced Inner Hair Cell Synaptopathy
Dorit Möhrle, Katrin Reimann, Steffen Wolter, et al.
Kidney International
|
November 21, 2024
Activating soluble guanylyl cyclase attenuates ischemic kidney damage
Falk-Bach Lichtenberger, Minze Xu, Cem Erdoğan, et al.
BJU International
|
October 21, 2016
Additive effects of the Rho kinase inhibitor Y-27632 and vardenafil on relaxation of the corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure
Pieter Uvin, Maarten Albersen, Ine Bollen, et al.
Journal of Hypertension
|
April 8, 2025
The treatment with soluble guanylate cyclase stimulator BAY41-8543 prevents malignant hypertension and associated organ damage
Martina Hüttl, Matúš Miklovič, Olga Gawryś, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 109) with videos related to
Sort By:
Page
of 11
Scientific Reports
|
March 5, 2022
The sGC stimulator BAY-747 and activator runcaciguat can enhance memory in vivo via differential hippocampal plasticity mechanisms
Ellis Nelissen, Nina Possemis, Nick P Van Goethem, et al.
Nitric Oxide : Biology and Chemistry
|
December 6, 2021
Capillary hemodynamics and contracting skeletal muscle oxygen pressures in male rats with heart failure: Impact of soluble guanylyl cyclase activator
Ramona E Weber, Kiana M Schulze, Trenton D Colburn, et al.
The Journal of Sexual Medicine
|
April 24, 2010
Sex steroid receptors in male human bladder: expression and biological function
Aravinda K Chavalmane, Paolo Comeglio, Annamaria Morelli, et al.
Experimental Physiology
|
June 20, 2025
Effects of soluble guanylyl cyclase stimulation on muscle oxygenation and exercise capacity in heart failure with mildly reduced ejection fraction
Ramona E Weber, Kiana M Schulze, Andrew G Horn, et al.
British Journal of Pharmacology
|
June 25, 2026
Pharmacological activation of NO-cGMP signalling attenuates metabolic dysfunction-associated steatohepatitis
Krithika Rajeeth, Malte Roessing, Moritz Lehners, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
September 22, 2021
Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney disease
Agnès Bénardeau, Antje Kahnert, Tibor Schomber, et al.
Molecular Pharmacology
|
September 7, 2017
NO-Sensitive Guanylate Cyclase Isoforms NO-GC1 and NO-GC2 Contribute to Noise-Induced Inner Hair Cell Synaptopathy
Dorit Möhrle, Katrin Reimann, Steffen Wolter, et al.
Kidney International
|
November 21, 2024
Activating soluble guanylyl cyclase attenuates ischemic kidney damage
Falk-Bach Lichtenberger, Minze Xu, Cem Erdoğan, et al.
BJU International
|
October 21, 2016
Additive effects of the Rho kinase inhibitor Y-27632 and vardenafil on relaxation of the corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure
Pieter Uvin, Maarten Albersen, Ine Bollen, et al.
Journal of Hypertension
|
April 8, 2025
The treatment with soluble guanylate cyclase stimulator BAY41-8543 prevents malignant hypertension and associated organ damage
Martina Hüttl, Matúš Miklovič, Olga Gawryś, et al.
Page
of 11